The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
BID: a novel BH3 domain-only death agonist.
Open accessAbstract
The BCL-2 family of proteins consists of both antagonists (e.g., BCL-2) and agonists (e.g., BAX) that regulate apoptosis and compete through dimerization. The BH1 and BH2 domains of BCL-2 are required to heterodimerize with BAX and to repress cell death; conversely, the BH3 domain of BAX is required to heterodimerize with BCL-2 and to promote cell death. To extend this pathway, we used interactive cloning to identify Bid, which encodes a novel death agonist that heterodimerizes with either agonists (BAX) or antagonists (BCL-2). BID possesses only the BH3 domain, lacks a carboxy-terminal signal-anchor segment, and is found in both cytosolic and membrane locations. BID counters the protective effect of BCL-2. Moreover, expression of BID, without another death stimulus, induces ICE-like proteases and apoptosis. Mutagenesis revealed that an intact BH3 domain of BID was required to bind the BH1 domain of either BCL-2 or BAX. A BH3 mutant of BID that still heterodimerized with BCL-2 failed to promote apoptosis, dissociating these activities. In contrast, the only BID BH3 mutant that retained death promoting activity interacted with BAX, but not BCL-2. This BH3-only molecule supports BH3 as a death domain and favors a model in which BID represents a death ligand for the membrane-bound receptor BAX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Self-citationNagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Social controls on cell survival and cell death
Raff, M. C. (1992) · Nature · doi:10.1038/356397a0 · Cited by 2,604
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,562
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,479
Mechanisms and Functions of Cell Death
Ellis, R. E., Yuan, J., & Horvitz, H. R. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003311 · Cited by 2,057
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., et al. (1996) · Nature · doi:10.1038/381335a0 · Cited by 1,467
Cited by
Items 101–141 of 141
How the Bcl-2 family of proteins interact to regulate apoptosis
van Delft, M. F., & Huang, D. C. (2006) · Cell Research · doi:10.1038/sj.cr.7310028 · Cited by 335
Kajita, M., McClinic, K. N., & Wade, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.17.7559-7566.2004 · Cited by 333
Huang, D. C. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4628 · Cited by 333
Mitochondria—Judges and Executioners of Cell Death Sentences
Bhola, P. D., & Letai, A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.019 · Cited by 326
The E1B 19K/Bcl-2–binding Protein Nip3 is a Dimeric Mitochondrial Protein that Activates Apoptosis
Chen, G., Ray, R., Dubik, D., Shi, L., Cizeau, J., Bleackley, R. C., Saxena, S., Gietz, R. D., & Greenberg, A. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1975 · Cited by 332
Why do BCL-2 inhibitors work and where should we use them in the clinic?
Montero, J., & Letai, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.183 · Cited by 327
Reiners Jr, J. J., Caruso, J. A., Mathieu, P., Chelladurai, B., Yin, X.-M., & Kessel, D. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401048 · Cited by 326
Self-citationBax activation and mitochondrial insertion during apoptosis
Lalier, L., Cartron, P.-F., Juin, P., Nedelkina, S., Manon, S., Bechinger, B., & Vallette, F. M. (2007) · Apoptosis · doi:10.1007/s10495-007-0749-1 · Cited by 320
Bcl-XL Inhibits Membrane Permeabilization by Competing with Bax
Billen, L. P., Kokoski, C. L., Lovell, J. F., Leber, B., & Andrews, D. W. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060147 · Cited by 314
YIN, X.-M. (2000) · Cell Research · doi:10.1038/sj.cr.7290045 · Cited by 313
Self-citationGranzyme B–Mediated Cytochrome C Release Is Regulated by the Bcl-2 Family Members Bid and Bax
Heibein, J. A., Goping, I. S., Barry, M., Pinkoski, M. J., Shore, G. C., Green, D. R., & Bleackley, R. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1391 · Cited by 311
BH3-Triggered Structural Reorganization Drives the Activation of Proapoptotic BAX
Gavathiotis, E., Reyna, D. E., Davis, M. L., Bird, G. H., & Walensky, L. D. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.019 · Cited by 310
“The identification of a BID construct containing BH3 mutations that blocked BCL-2 interaction but retained BAX binding and killing activity led to the hypothesis that BID’s BH3 domain could directly trigger BAX/BAK by a ‘‘hit and run’’ mechanism (Wang et al., 1996; Wei et al., 2000).”
Nix and Nip3 Form a Subfamily of Pro-apoptotic Mitochondrial Proteins
Chen, G., Cizeau, J., Vande Velde, C., Park, J. H., Bozek, G., Bolton, J., Shi, L., Dubik, D., & Greenberg, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.7 · Cited by 310
BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic Activity
Zha, J., Harada, H., Osipov, K., Jockel, J., Waksman, G., & Korsmeyer, S. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24101 · Cited by 310
Self-citationBAD Ser-155 Phosphorylation Regulates BAD/Bcl-XL Interaction and Cell Survival
Tan, Y., Demeter, M. R., Ruan, H., & Comb, M. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004199200 · Cited by 309
Harris, C. A., & Johnson, E. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104073200 · Cited by 307
Mechanisms underlying hypoxia-induced neuronal apoptosis
Banasiak, K. J., Xia, Y., & Haddad, G. G. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00011-3 · Cited by 303
Caspases Induce Cytochrome c Release from Mitochondria by Activating Cytosolic Factors
Bossy-Wetzel, E., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17484 · Cited by 299
Bcl-2 family members and apoptosis, taken to heart
Gustafsson, Å. B., & Gottlieb, R. A. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00229.2006 · Cited by 291
Bae, J., Leo, C. P., Hsu, S. Y., & Hsueh, A. J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909826199 · Cited by 289
Marani, M., Tenev, T., Hancock, D., Downward, J., & Lemoine, N. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3577-3589.2002 · Cited by 286
Hematopoietic Malignancies Demonstrate Loss-of-Function Mutations ofBAX
Meijerink, J. P. P., Mensink, E. J. B. M., Wang, K., Sedlak, T. W., Slöetjes, A. W., de Witte, T., Waksman, G., & Korsmeyer, S. J. (1998) · Blood · doi:10.1182/blood.v91.8.2991.2991_2991_2997 · Cited by 286
Self-citationBillen, L. P., Shamas-Din, A., & Andrews, D. W. (2008) · Oncogene · doi:10.1038/onc.2009.47 · Cited by 278
Phosphorylation of BCL‐2 regulates ER Ca2+ homeostasis and apoptosis
Bassik, M. C., Scorrano, L., Oakes, S. A., Pozzan, T., & Korsmeyer, S. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600104 · Cited by 278
Self-citationBad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-X L
Kelekar, A., Chang, B. S., Harlan, J. E., Fesik, S. W., & Thompson, C. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7040 · Cited by 274
Shimizu, S., & Tsujimoto, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.577 · Cited by 273
A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System
Castelli, J. C., Hassel, B. A., Wood, K. A., Li, X.-L., Amemiya, K., Dalakas, M. C., Torrence, P. F., & Youle, R. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.967 · Cited by 270
Mimicking the BH3 domain to kill cancer cells
Chonghaile, T. N., & Letai, A. (2008) · Oncogene · doi:10.1038/onc.2009.52 · Cited by 268
Bad -deficient mice develop diffuse large B cell lymphoma
Ranger, A. M., Zha, J., Harada, H., Datta, S. R., Danial, N. N., Gilmore, A. P., Kutok, J. L., Le Beau, M. M., Greenberg, M. E., & Korsmeyer, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533446100 · Cited by 263
Self-citationCaspase-3 Promotes Genetic Instability and Carcinogenesis
Liu, X., He, Y., Li, F., Huang, Q., Kato, T. A., Hall, R. P., & Li, C.-Y. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.003 · Cited by 263
In stent restenosis: bane of the stent era
Mitra, A. K., & Agrawal, D. K. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.025742 · Cited by 260
Cartron, P.-F., Gallenne, T., Bougras, G., Gautier, F., Manero, F., Vusio, P., Meflah, K., Vallette, F. M., & Juin, P. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.028 · Cited by 255
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias
Tzifi, F., Economopoulou, C., Gourgiotis, D., Ardavanis, A., Papageorgiou, S., & Scorilas, A. (2012) · Advances in Hematology · doi:10.1155/2012/524308 · Cited by 254
Weng, C., Li, Y., Xu, D., Shi, Y., & Tang, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412819200 · Cited by 254
BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia
Plesnila, N., Zinkel, S., Le, D. A., Amin-Hanjani, S., Wu, Y., Qiu, J., Chiarugi, A., Thomas, S. S., Kohane, D. S., Korsmeyer, S. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261323298 · Cited by 253
Self-citationA Role for Proapoptotic BID in the DNA-Damage Response
Zinkel, S. S., Hurov, K. E., Ong, C., Abtahi, F. M., Gross, A., & Korsmeyer, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.06.022 · Cited by 239
Self-citationWalensky, L. D., & Gavathiotis, E. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.08.009 · Cited by 173
Small molecule modulators of protein-protein interactions: selected case studies
Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79
MOAP-1 Mediates Fas-Induced Apoptosis in Liver by Facilitating tBid Recruitment to Mitochondria
Tan, C. T., Zhou, Q.-L., Su, Y.-C., Fu, N. Y., Chang, H.-C., Tao, R. N., Sukumaran, S. K., Baksh, S., Tan, Y.-J., Sabapathy, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.068 · Cited by 35
Wu, Y., Xing, D., Liu, L., & Gao, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.006 · Cited by 24
Computational design of Bax-inhibiting peptides
Vlaar, T., Mayer, B., van der Heide, L., & Ilie, I. M. (2025) · Materials Advances · doi:10.1039/d4ma01142b · Cited by 2
Metadata
- Authors
- Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., & Korsmeyer, S. J.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1996-11-15
- Volume
- 10
- Issue
- 22
- Pages
- 2859-2869
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2105253445
- Cited by
- 946
- References
- 39
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.